Related content

Stereotactic Body Radiation Therapy for Stage I Non-small-cell Lung Cancer: A Historical Overview of Clinical Studies

By Onishi Hiroshi   Araki Tsutomu  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 4, 2013-04 ,pp. : 345-350

Oxford University Press

Access to resources Recommend Favorite

Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the Japanese experience

By Hiraoka Masahiro   Nagata Yasushi  

International Journal of Clinical Oncology, Vol. 9, Iss. 5, 2004-10 ,pp. : 352-355

Springer Publishing Company

Access to resources Recommend Favorite

Patient versus clinician preferences for chemotherapy in non-small-cell lung cancer

By Long Anne   Ferraro Danielle   Stockler Martin   Blinman Prunella  

Lung Cancer Management, Vol. 2, Iss. 6, 2013-12 ,pp. : 527-536

Future Medicine

Access to resources Recommend Favorite

Is EGF receptor–tyrosine kinase inhibitor therapy in non-small-cell lung cancer patients with EGFR mutations the best option?

By Hayashi Hidetoshi   Nakagawa Kazuhiko  

Lung Cancer Management, Vol. 2, Iss. 6, 2013-12 ,pp. : 441-443

Future Medicine

Access to resources Recommend Favorite

Targeted therapy for non-small-cell lung cancer: past, present and future

By Forde Patrick M   Ettinger David S  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 6, 2013-06 ,pp. : 745-758

Informa Healthcare

Access to resources Recommend Favorite